I think just proving ddRNAi works in humans will suffice even if it is too late for TT-034 to be of any use to anyone. The important thing is we will soon have multiple drugs in the clinic with Tribetarna. That alone could be enormous. Plus Cal-1. I think we will be alright even if TT-034 never is commercialized.
- Forums
- ASX - By Stock
- BLT
- Hep C - adherence issues
Hep C - adherence issues, page-3
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some